Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DWP450 in Benign Masseteric Hypertrophy
NCT03369990Phase 2Unknown
- Sponsor
- Daewoong Pharmaceutical
- Start
- Dec 2017
- Primary completion
- Oct 2018
- Modality
- Recombinant Proteins and Enzymes
01
Overview
A Phase 2 trial of prabotulinumtoxinA in benign masseteric hypertrophy (BMH), sponsored by Daewoong Pharmaceutical. Status: unknown.
02
Drugs
prabotulinumtoxinA
03
Conditions
benign masseteric hypertrophy (BMH)
Beyond the preview
Go deeper on NCT03369990.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03369990.